Eubiotics Market Size, Share, Trends, Report 2026 To 2035

Eubiotics Market Size, Forecast Report 2026 To 2035

The eubiotics market size was valued at USD 6.41 billion in 2025, the market is observed to reach at USD 12.53 billion by 2035. Considering the forecast period of 2026-2035, the market is seen to expand at a CAGR of 6.9%.

Report Highlights

• By region, Europe dominated the eubiotics market with a 39.0% revenue share in 2025, supported by mature animal nutrition markets, advanced feed manufacturing, stringent animal-health standards, and increasing demand for antibiotic-reduction solutions.
• By region, Asia-Pacific is expected to be the fastest-growing regional market, with its share increasing from 32.0% in 2025 to 37.0% by 2035 at a 8.6% CAGR, driven by large livestock populations, expanding compound-feed production, and modernization of animal farming.
• By product type, probiotics dominated the eubiotics market with a 40.0% revenue share in 2025 and are projected to reach 42.0% by 2035, supported by increasing demand for gut-health, digestive-performance, and microbial-balance solutions.
• By product type, phytogenics recorded the fastest growth at a 7.7% CAGR from 2026 to 2035, with its market share increasing from 10.0% in 2025 to 10.7% by 2035 as producers increasingly adopt plant-derived feed additives.
• By livestock, poultry dominated the eubiotics market with a 37.0% revenue share in 2025, driven by intensive commercial production, high feed consumption, and increasing focus on gut health, feed conversion, and productivity.
• By livestock, aquaculture is projected to be the fastest-growing segment at an 11.3% CAGR from 2026 to 2035, with its share rising from 9.0% in 2025 to 13.0% by 2035 amid increasing demand for feed-efficiency and health-management solutions.
• By function, nutrition & gut health dominated the eubiotics market with a 43.0% share in 2025, reflecting the central role of eubiotics in supporting intestinal microbial balance, nutrient utilization, digestion, and feed efficiency.
• By function, production & performance was the second-largest segment with a 30.0% share in 2025, supported by increasing use of eubiotics to improve feed conversion, weight gain, growth efficiency, milk production, and overall livestock productivity.
• By dosage form, dry eubiotics dominated the market with a 78.0% share in 2025, supported by their compatibility with compound-feed manufacturing, ease of transportation and storage, and suitability for large-scale livestock feeding programs.
• By dosage form, liquid eubiotics are gaining importance, with their share projected to increase from 22.0% in 2025 to 25.0% by 2035, driven by flexible dosing, drinking-water applications, and increasing adoption of on-farm supplementation systems.

Market Dynamics

Driver

Rising Adoption of Antibiotic-Reduction and Gut-Health Solutions

The eubiotics market is also propelled by the growing emphasis on antibiotic-reduction strategies, where the demand for feed additives that can promote growth and health without heavy reliance on antibiotic growth promoters in livestock production rises. 

Hence, the use of probiotics, prebiotics, organic acids, phytogenics and postbiotics is steadily increasing in feed regimes to enhance microfloral balance in the gut, aid nutrient utilization, promote immunity and boost feed conversion efficiency (FCE). 

This shift is particularly evident within intensive poultry and swine production where small improvement in FCE and animal performance could bring about substantial economic returns. Increased demand is therefore observed in the production of multi-functional eubiotic feeds.

Restraint

Inconsistent Product Performance and Formulation Complexity

Variability in eubiotic performance remains a key restraint because efficacy can differ according to animal species, age, genetics, feed composition, dosage, farm conditions, and environmental factors. Probiotic viability, for example, can be affected by feed-processing temperatures and storage conditions, while phytogenic and organic-acid formulations may require precise combinations to achieve consistent outcomes.

Manufacturers therefore need extensive testing to demonstrate repeatable benefits in commercial conditions. These formulation and validation requirements increase R&D costs and can make product development more complex, particularly for companies attempting to expand eubiotic products across multiple livestock species and geographic markets.

Opportunity

Rapid Expansion of Aquaculture and Advanced Microbiome-Based Nutrition

Aquaculture is currently one of the most potent opportunities for eubiotics and is expected to grow to contribute 13% of the global eubiotic market by 2035, from 9% in 2025, with a supplied CAGR of 11.3%. Intensive fish and shrimp farming calls for solutions that improve feed utilisation and digestion; disease resistance and microbial balance; all while decreasing antibiotic use, opening the door to tailor-made probiotics, postbiotics, organic acids and phytogenic solutions that work in aquaculture settings.

Besides this, as industry transitions towards ‘precision eubiotics’, which involves the integration of multiple active ingredients into a single solution to promote both gut health, feed efficiency, immune response, and overall productivity, the microbiome formulation trend will see further disruption.

Segmental Insights

Product Type Insights

Probiotics commanded the eubiotics market in 2025, accounting for a 40.0% revenue share. The segment is expected to expand its share of the market to 42.0% by 2035. Probiotics are the most widely used form of eubiotics in livestock production, driven by their ability to bolster animal resistance, enhance gut function, support nutrient utilization, and maintain gut health among poultry, swine, ruminants and aquatic animals. 

The increasing adoption of intensive livestock systems, particularly in the APAC region, where a significant volume of feed is consumed has resulted in a strong increase in demand for probiotics in livestock feed.

Phytogenics are the fastest-growing product type in the supplied dataset, with a 7.7% CAGR during 2026–2035. Their share is expected to increase from 10.0% in 2025 to 10.7% in 2035. Phytogenic feeds are gain traction among livestock operators seeking to provide plant-extracted additives to animals as they assist gut health, optimize feed intake and animal performance while working as suitable replacement for antibiotics.

Their use in poultry and swine feed sectors for large-scale integration into feed formulations represents a substantial demand as their growth reflects diversification within formulations beyond simple microbials.

Livestock Insights

Poultry held dominant position in the eubiotics market with significant revenue contribution of 37.0% in 2025 by livestock application. Its market share is predicted to decline to 34.0% by 2035. The largest application base for the market relies on intensive cultivation cycles, optimum feed consumption, larger farm sizes and need to preserve feed conversion, along with the animal’s intestinal health. Poultry is expected to grow due to enhanced uptake in the nutrition programs incorporated along with probiotic, organic acids, phytogenic along with other gut related solution for optimal performance.

Aquaculture is the fastest-growing livestock segment, recording an 11.3% CAGR from 2026 to 2035. Its share is projected to increase substantially from 9.0% in 2025 to 13.0% in 2035. This expansion reflects the increasing need for feed-efficiency, disease-management, digestive-health, and water-quality solutions in intensive fish and shrimp farming. Eubiotics can be incorporated into aquafeed to support microbial balance and animal resilience while improving production efficiency.

Function Insights

Nutrition & gut health remained the largest functional segment by value and share in 2025, at 43.0% of the global eubiotics market. This dominance stems from eubiotics' key use to promote optimal intestinal microbial balance, enhance utilization of nutrients, and improve digestive functions & feed conversion. This segment particularly concerns high-performance intensive livestock sectors, most notably in poultry and swine, where marginal increases in feed conversion could deliver substantial cost efficiencies at a commercial level.

Production & performance proved to the second largest functional segment in 2025 with 30.0% share of the overall eubiotics market. In this segment, eubiotics solutions are increasingly targeting on outcomes which can easily be monitored, specifically on feed conversion, milk production, egg production, growth efficiencies and general productive performance. Such segmentation highlights the increasing imperative faced by manufacturers to deliver higher volumes whilst keeping feed costs to a minimal, and animal health optimally balanced.

Dosage Form Insights

Dry eubiotics have a dominant position in the market with a 78.0% market share in 2025. In terms of application they are integrated during the compound feed production process, a relatively easy storage, transportation and integration to premixes as well as they are suitable for intensive animal feeding. The dry eubiotics are readily mixable with the feed during standard compound feed production and thus transportable to commercially supplied animal farms without a dedicated liquid distribution system.

Liquid eubiotics had a market share of 22.0% in 2025, it is expected to grow up to 25.0% by 2035. Increasing share in the market can be attributed by drinking water administration, supplemented on the farm, automated integration with the feeding systems and its flexibility in the formulation to be supplemented to the animals according to different stage of their life.

Regional Insights

How Did Europe Dominate the Eubiotics Market in 2025?

Europe held a 39.0% revenue share in 2025 in the eubiotics market globally. An experienced feed manufacturing process, well-established feed markets and stringent animal-health standards supported Europe’s lead with strong demand for gut-health solutions to replace conventional antibiotic growth promoters. The continent, in Europe is focusing more on the animal-microbiome interaction, feed efficiencies and animal welfare in intensive animal production. 

High concentration of livestock producers and sophisticated compound-feed industries, and intense livestock population in countries such as Germany, France, Spain, the Netherlands and the UK made Europe a large demand center.

• Within Europe, Germany, France, Spain, the United Kingdom, Italy, and the Netherlands represent important eubiotics markets, supported by established compound-feed production, intensive poultry and swine farming, and strong demand for antibiotic-reduction strategies.
• Germany and France provide large feed and livestock bases, while Spain's extensive pork and poultry industries create substantial demand for probiotics, organic acids, and phytogenic additives.
• The Netherlands is particularly relevant because of its sophisticated livestock and feed-technology ecosystem, whereas the UK is increasingly focused on gut-health solutions aligned with sustainable animal production.

How is Asia Pacific Expanding in the Eubiotics Market?

Asia Pacific is estimated to be the highest growing region and expanding its market share from 32.0% in 2025 to 37.0% by 2035, at a 8.6% CAGR in 2026-2035. High livestock population, increasing compound feed production and growing use of the solutions, coupled with increasing modernization of livestock farming. China is considered the major market for the feed probiotics in Asia Pacific and had a market share of around 43.25% in the region in 2025. Historically China, India, Japan are the largest markets in the region.

• Within Asia-Pacific, China, India, Japan, South Korea, and Australia represent key country markets, with China serving as the largest regional demand center.
• India offers significant long-term potential because of its large poultry, dairy, and aquaculture industries.
• Japan and South Korea benefit from technologically advanced feed industries and increasing emphasis on animal productivity and functional nutrition.

Major Players

• DSM
• Alltech
• BASF
• Dupont
• Cargill
• Novozymes
• Friesland Campina
• Chr. Hansen
• Lesaffre Group
• Kemin Industries
• Lallemand, Inc.
• Calpis
• Friesland Campina
• Novus International

Recent News

• DSM-Firmenich announce that it is currently promoting GutServ Biotics, a postbiotic feed additive for poultry, swine, ruminants, and aquaculture. The company reports an ROI of 5:1–10:1 in swine and up to 13:1 in aquaculture, highlighting the commercial shift toward stable postbiotic solutions for gut integrity, immunity, and production performance.

Segments Covered

By Product Type

• Probiotics
• Prebiotics
• Organic Acids
• Phytogenics
• Postbiotics
• Other

By Livestock

• Poultry
• Swine
• Ruminants
• Aquaculture
• Companion Animals
• Other Animals

By Function

• Nutrition & Gut Health
• Immunity
• Production & Performance
• Environmental & Other

By Dosage Form

• Dry
• Liquid

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa